ILP-2 anticorps (AA 2-13)
Aperçu rapide pour ILP-2 anticorps (AA 2-13) (ABIN2287150)
Antigène
Voir toutes ILP-2 (BIRC8) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 2-13
-
Séquence
- TGYEARLITF GT
-
Réactivité croisée
- Humain, Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo Rt
-
Attributs du produit
- IAP-Like Protein 2 (ILP 2, Inhibitor of Apoptosis Protein)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Raised with a synthetic peptide (TGYEARLITFGT) corresponding to amino acids 2 to 13 of human ILP-2 (1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ILP-2 (BIRC8) (Baculoviral IAP Repeat-Containing 8 (BIRC8))
-
Autre désignation
- IAP-Like Protein 2
Antigène
-